Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
0Activity
0 of .
Results for:
No results containing your search query
P. 1
Handout_-_PBM_BTM-_L1_to_L4

Handout_-_PBM_BTM-_L1_to_L4

Ratings: (0)|Views: 5 |Likes:
Published by Bob Bin

More info:

Published by: Bob Bin on Nov 17, 2011
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PPTX, PDF, TXT or read online from Scribd
See more
See less

05/02/2012

pdf

text

original

 
1
100 Marks
Internal Assessment
Total 5 Modules covered in 12 Lectures
 
Biotech Sector Outlook
Growth in India is primarily export-driven.
 
Export sales of Indian biopharmaceutical products are currently rising at an annual rate of 47%,
domestic sales of Indian biopharmaceutical products have risen only 4
 –
5% per annum
Vaccines are the largest and fastest-growing sector.
 
Indian vaccine sales currently account for about 43% of the country's total biopharmaceutical sales,
16% for diagnostics
13% for therapeutics.
Most of the growth in Indian biopharmaceuticals is because of vaccines
India is one of the world's leading suppliers of vaccines for measles and other childhood vaccinations.
1
 
Industry growth is concentrated in a relatively small number of companies.
 
About 30 Indian companies account for the great majority of the country's biopharmaceutical sales.
Indian companies manufacture an increasingly wide range of biopharmaceuticalproducts.
These include recombinant insulin, erythropoietin (EPO), G-CSF, recombinant hepatitis-B vaccine,streptokinase, interferon alpha-2b, rituximab, and an anti-EGFR MAb product.
1,2
 
Indian biopharmaceutical R&D is increasing rapidly.
 
2
 
Top ranking Bio-Pharma companiesin India
3

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->